Skip to main content

D. E. Shaw & Co., Inc.

Position in WGS — GeneDx Holdings Corp.

CIK 1009207 New York, NY

Position in WGS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,668,905
+$1,454,955 QoQ
Shares Held
38,877
+105.7% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 223 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in WGS Over Time

Shares Held

Position Value (USD)

Derivatives in WGS

reported options exposure · as of Jun 30, 2026
CallValue
$2,622,430
CallShares
38,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $2,165,536,060 across 26 Diagnostics & Research names. WGS ranks #23 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in WGS

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,668,905 38,877
2026-06-30 $2,622,430 38,200
2026-03-31 $1,213,950 18,903
2026-03-31 $2,010,086 31,300
2025-12-31 $2,145,990 16,500
2025-12-31 $2,029,325 15,603
2025-12-31 $260,120 2,000
2025-09-30 $3,576,968 33,200
2025-09-30 $441,734 4,100
2025-06-30 $2,972,382 32,200
2025-06-30 $2,095,437 22,700
2025-06-30 $845,098 9,155
2025-03-31 $531,390 6,000
2025-03-31 $673,094 7,600
2025-03-31 $35,399,784 399,704
2024-12-31 $276,696 3,600
2024-12-31 $22,636,576 294,517
2024-12-31 $222,894 2,900
2024-09-30 $971,876 22,900
2024-09-30 $1,332,234 31,391
2022-12-31 $171,631 650,122
2022-09-30 $795,129 905,615
2022-06-30 $3,851,118 3,056,444
2022-03-31 $5,633,488 1,835,013
2021-12-31 $6,364,825 1,427,091
2021-09-30 $10,637,855 1,401,562
2021-06-30 CMLF 1,201,562
2021-03-31 CMLF 1,378,780